Skip to main content
Erschienen in: Journal of Neurology 3/2019

25.01.2019 | Original Communication

Tollgate-based progression pathways of ALS patients

verfasst von: Özden O. Dalgıç, F. Safa Erenay, Kalyan S. Pasupathy, Osman Y. Özaltın, Brian A. Crum, Mustafa Y. Sir

Erschienen in: Journal of Neurology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To capture ALS progression in arm, leg, speech, swallowing, and breathing segments using a disease-specific staging system, namely tollgate-based ALS staging system (TASS), where tollgates refer to a set of critical clinical events including having slight weakness in arms, needing a wheelchair, needing a feeding tube, etc.

Methods

We compiled a longitudinal dataset from medical records including free-text clinical notes of 514 ALS patients from Mayo Clinic, Rochester-MN. We derived tollgate-based progression pathways of patients up to a 1-year period starting from the first clinic visit. We conducted Kaplan–Meier analyses to estimate the probability of passing each tollgate over time for each functional segment.

Results

At their first clinic visit, 93%, 77%, and 60% of patients displayed some level of limb, bulbar, and breathing weakness, respectively. The proportion of patients at milder tollgate levels (tollgate level < 2) was smaller for arm and leg segments (38% and 46%, respectively) compared to others (> 65%). Patients showed non-uniform TASS pathways, i.e., the likelihood of passing a tollgate differed based on the affected segments at the initial visit. For instance, stratified by impaired segments at the initial visit, patients with limb and breathing impairment were more likely (62%) to use bi-level positive airway pressure device in a year compared to those with bulbar and breathing impairment (26%).

Conclusion

Using TASS, clinicians can inform ALS patients about their individualized likelihood of having critical disabilities and assistive-device needs (e.g., being dependent on wheelchair/ventilation, needing walker/wheelchair or communication devices), and help them better prepare for future.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
9.
Zurück zum Zitat Brooks BR (1996) Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 47:S71–S82CrossRefPubMed Brooks BR (1996) Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 47:S71–S82CrossRefPubMed
19.
Zurück zum Zitat Bird S (2006) NLTK: the natural language Toolkit Steven. In: Proceedings of the COLING/ACL on Interactive presentation sessions. Association for Computational Linguistics, Morristown, NJ, USA, pp 69–72 Bird S (2006) NLTK: the natural language Toolkit Steven. In: Proceedings of the COLING/ACL on Interactive presentation sessions. Association for Computational Linguistics, Morristown, NJ, USA, pp 69–72
31.
Zurück zum Zitat Cedarbaum JM, Stambler N (2001) Disease status and use of ventilatory support by ALS patients. Amyotroph lateral Scler other Mot neuron Disord 2:19–22CrossRef Cedarbaum JM, Stambler N (2001) Disease status and use of ventilatory support by ALS patients. Amyotroph lateral Scler other Mot neuron Disord 2:19–22CrossRef
37.
Zurück zum Zitat Montes J, Levy G, Albert S et al (2006) Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 67:1294–1296CrossRefPubMed Montes J, Levy G, Albert S et al (2006) Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 67:1294–1296CrossRefPubMed
Metadaten
Titel
Tollgate-based progression pathways of ALS patients
verfasst von
Özden O. Dalgıç
F. Safa Erenay
Kalyan S. Pasupathy
Osman Y. Özaltın
Brian A. Crum
Mustafa Y. Sir
Publikationsdatum
25.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09199-y

Weitere Artikel der Ausgabe 3/2019

Journal of Neurology 3/2019 Zur Ausgabe

Pioneers in Neurology

George Huntington (1850–1916)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.